Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Actos Federal Multidistrict Litigation Moves Forward: Now, AttorneyOne Can Provide Advice

03:00 EST 1 Jan 2014 | PR Web

According to court documents, the next Status Conference in the Actos federal Multidistrict Litigation has been scheduled for January 23. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Actos side effects.

San Diego, CA (PRWEB) January 01, 2014

AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion, taking into consideration the recent news on Actos Problems and Actos lawsuits.

According to court documents, the next Status Conference in the Actos federal Multidistrict Litigation has been scheduled for January 23 (MDL 2299, US District Court for the Western District of Louisiana). Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance.

Court data updated* by the Judicial Panel on Multidistrict Litigation on December 16, indicate that there are 2,675 cases pending in the Actos Multidistrict Litigation.

A new lawsuit was filed on December 10, by a New Hampshire couple in Louisiana Western District Court (case no. 6:2013cv03215) alleging that the husband suffered bladder cancer from Actos. In the lawsuit, the plaintiff claims that he began taking Actos in 2003 and, in 2009, he was diagnosed with bladder cancer.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in cases of severe complications, allegedly from Actos. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Actos lawsuits. "For that reason," he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On September 25, Businessweek published that "Takeda Pharmaceutical Co. duped patients and doctors about the risks of its Actos diabetes drug and should be held liable for the cancer death of a former U.S. Army translator, a lawyer argued in the second case over the medicine to go to trial." (Case no. 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland).

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/12/prweb11448650.htm

  • jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_by_MDL_Number-December-16-2013.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11451325.htm

NEXT ARTICLE

More From BioPortfolio on "Actos Federal Multidistrict Litigation Moves Forward: Now, AttorneyOne Can Provide Advice"

Search BioPortfolio:

Relevant Topic

The Top 100 Pharmaceutical Companies · Latest News · Clinical Trials · Research · Drugs · Reports · Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement
Advertisement

Searches Linking to this Story